Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.

@article{Maio2015SymptomaticTE,
  title={Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.},
  author={Massimo Di Maio and Ciro Gallo and Natasha B Leighl and Maria Carmela Piccirillo and Gennaro Daniele and Francesco Nuzzo and Cesare Gridelli and Vittorio Gebbia and Fortunato Ciardiello and Sabino De Placido and Anna Ceribelli and Adolfo Favaretto and Andrea de Matteis and Ronald Feld and Charles Butts and J. G. Bryce and Simona Signoriello and Alessandro Morabito and Gaetano Rocco and Francesco Perrone},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2015},
  volume={33 8},
  pages={910-5}
}
PURPOSE Information about symptomatic toxicities of anticancer treatments is not based on direct report by patients, but rather on reports by clinicians in trials. Given the potential for under-reporting, our aim was to compare reporting by patients and physicians of six toxicities (anorexia, nausea, vomiting, constipation, diarrhea, and hair loss) within three randomized trials. PATIENTS AND METHODS In one trial, elderly patients with breast cancer received adjuvant chemotherapy; in two… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 134 times over the past 90 days. VIEW TWEETS